Elucida Oncology, Inc.
Biotechnology company · Monmouth Junction, New Jersey, United States
Elucida Oncology, Inc. is a biotechnology company headquartered in Monmouth Junction, New Jersey, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $22 million sold in a notice filed in 2023.
Elucida Oncology at a glance
What does Elucida Oncology do?
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $22.3 million sold (2023).
Frequently asked questions about Elucida Oncology
Where is Elucida Oncology headquartered?
Elucida Oncology, Inc. is headquartered in Monmouth Junction, New Jersey, United States.
What does Elucida Oncology do?
Elucida Oncology, Inc. is a biotechnology company.
When was Elucida Oncology founded?
The earliest incorporation on record for Elucida Oncology, Inc. is in 2014, according to public company registers.
Similar companies
- Signum Biosciences, Inc.Monmouth Junction, New Jersey, United States
- Pharmaseq, IncMonmouth Junction, New Jersey, United States
- Notitia Biotechnologies CoMonmouth Junction, New Jersey, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences